Association of hepatitis C infection and acute coronary syndrome: A case-control study.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
28 May 2021
Historique:
received: 23 12 2020
accepted: 03 05 2021
entrez: 25 5 2021
pubmed: 26 5 2021
medline: 4 6 2021
Statut: ppublish

Résumé

Infections with hepatitis C virus (HCV) represent a substantial national and international public health burden. HCV has been associated with numerous extrahepatic conditions and can lead to metabolic derangements that are associated with atherosclerosis and cardiovascular disease. We investigated whether HCV infection is associated with an increased number of acute coronary syndrome (ACS) events among hospitalized patients in an inner-city tertiary hospital.We performed a matched (age, sex, and race/ethnicity) case-control study on patients at least 18 years old admitted to inpatient medical and cardiac services at the University of Maryland Medical Center from 2015 through 2018. The primary outcome was ACS and the primary exposure was HCV infection. Covariates of interest included: alcohol use, tobacco use, illicit drug use, hypertension, diabetes mellitus, human immunodeficiency virus infection, body mass index, dyslipidemia, and family history of coronary heart disease. Covariates with significant associations with both exposure and outcome in bivariate analyses were included in the multivariable analyses of the final adjusted model.There were 1555 cases and 3110 controls included in the final sample. Almost 2% of cases and 2.4% of controls were HCV infected. In adjusted models, there was no significant association found between experiencing an ACS event in those with HCV infection compared to those without HCV infection (odds ratio 0.71, 95% confidence interval 0.45-1.11).We found no significant association between HCV infection and ACS in our study population. However, given the mixed existing literature, the association between HCV and ACS warrants further investigation in future prospective cohort and/or interventional studies.

Identifiants

pubmed: 34032724
doi: 10.1097/MD.0000000000026033
pii: 00005792-202105280-00034
pmc: PMC8154507
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26033

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL133358
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI120834
Pays : United States
Organisme : NHLBI NIH HHS
ID : 5K23HL133358
Pays : United States

Informations de copyright

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Hepatology. 2009 Apr;49(4):1335-74
pubmed: 19330875
J Hepatol. 2014 Nov;61(1 Suppl):S69-78
pubmed: 25443347
Health Serv Res. 2013 Feb;48(1):290-318
pubmed: 22742621
Am J Epidemiol. 2020 Jun 1;189(6):554-563
pubmed: 31712804
Am J Cardiol. 2014 Dec 15;114(12):1841-5
pubmed: 25438910
J Viral Hepat. 2012 Apr;19(4):271-7
pubmed: 22404725
J Clin Transl Hepatol. 2017 Dec 28;5(4):343-362
pubmed: 29226101
Aliment Pharmacol Ther. 2013 Mar;37(6):647-52
pubmed: 23384408
Clin Infect Dis. 2009 Jul 15;49(2):225-32
pubmed: 19508169
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Ann Intern Med. 2006 May 16;144(10):705-14
pubmed: 16702586

Auteurs

Angela Wu (A)

University of Maryland School of Medicine, Baltimore, MD.

Shana Burrowes (S)

Section of Infectious Diseases, Boston University School of Medicine, Boston, MA.

Erin Zisman (E)

University of Maryland School of Medicine, Baltimore, MD.

Todd Tarquin Brown (TT)

Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University.

Shashwatee Bagchi (S)

Section of Infectious Diseases, University of Maryland School of Medicine.
Institute of Human Virology, University of Maryland School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH